Back to
Sumitomo Mitsui Trust Group, Inc.
NTLA30 quarters
Position history for
Sumitomo Mitsui Trust Group, Inc.'s holdings in INTELLIA THERAPEUTICS INC
Yes. Sumitomo Mitsui Trust Group holds 2,897,529 shares of NTLA (Intellia Therapeutics), worth $49M, as of its Q2 2026 13F filing. It increased the position by 924,468 shares (+46.9%) from Q1 2026. Sumitomo Mitsui Trust Group has held NTLA in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$49M
Current Shares
2.9M
Total Value Change
+$31.1M
Total Shares Change
+1.9M
Quarter-by-Quarter History
Other major holders of NTLA: ARK Investment Management LLC